InvestorsHub Logo
Followers 4
Posts 119
Boards Moderated 0
Alias Born 10/17/2011

Re: None

Friday, 04/18/2014 9:43:12 AM

Friday, April 18, 2014 9:43:12 AM

Post# of 263761
GCBD vs. MJN@

OK, MJN@ is medical marijuana penny stock that went from trips to .40 cents and back down to .20 cents/share currently.

What is the major difference between GCBD and MJN@? Will they both be competing to sell MM at dispensaries in CO, CA, WA and all other MM legal states?

What does GCBD have that would interest an institutional investor? I know nobody knows exactly, because Calkin hasn't revealed it yet but what are the possibilities moving forward that makes this a desirable investment.


From what I've learned in my DD and here on these boards, is that Calkin has literally thousands of former students all over the US. IMO, the winner in all of this will be the one that can most effectively deliver this newly legal product to the consumer. If he has an "in" with 450 of the next 500 dispensaries that open to stock their shelves with GCBD's products...well, that seems pretty strong.

The analogy would be...imagine you if manufactured a new line of tires, and you felt your tire was as good or better than any other tire out there. Having a superior product doesn't mean jack unless you can get it in front of consumers. Now imagine your last name is Firestone and you have 1,100 retail stores across the country that already sell your products. It would say that would be a pretty likely case for success, at least the opportunity for it.

What say you? I'm sure there are countless other revenue streams I'm not aware of, any ideas?